Ind-Swift Laboratories Ltd
Ind-Swift Laboratories Ltd - About the company
A division of the Ind-swift Group, Ind-Swift Laboratories was founded in the year 1995. This leading pharmaceutical company went public in the year 1997. Ind-Swift Limited in collaboration with Punjab State Industrial Development Corporation Limited (PSIDC) promoted the growth of this firm. Within few years of its establishment, Ind-Swift Laboratories Ltd has earned world wide recognition as well as a Bulk-Actives supplier in over 40 countries.
The company mainly bases its production in the creation of Active Pharmaceutical Ingredients or API. Besides, its involvement in organic synthetic chemistry has helped Ind-Swift Laboratories Ltd. to emerge as leader in the production of various products not only in the Indian subcontinent as well as throughout the world. The products manufactured by this company include capsule, oral solution, eye and ear drops, tablets, creams and gels. The products manufactured by Ind-Swift Laboratories Ltd are mainly used in the antiallergy, macrolide antibiotic, diabetology, antiulcerant, cardiovascular therapeutic sector.
The manufacturing plants of the company engage in the production of USFDA approved products. In addition, the company follows a long term policy in various regulated markets such as drugs which is worth US $80 billion, in order to maintain its quality production. The shares of Ind-Swift Laboratories Ltd. are listed on Bombay, Delhi, National and Ludhiana stock exchanges.
Ind-Swift Laboratories Ltd is also engaged in research and development, commonly known as R&D. The company involves in the research for advanced intermediates, non-infringing processes development for promising molecules, contract research, process optimization as well as improvement, contract manufacturing and many more.
Ind-Swift Laboratories Ltd - Management
The management details of Ind-Swift Laboratories Ltd are mentioned below:
Chairperson - S R Mehta
MD - N R Munjal
Chief Operating Officer - L K Wadhwa
Nominee Director - IFCI - S P Sharma
Joint Managing Director - Himanshu Jain
Independent Director - Pradeep Kumar
The members of the board of director of Ind-Swift Laboratories Ltd are
V R Mehta
G Munjal
J K Kakkar
K M S Nambiar
H P S Chawla
N D Aggarwal
Rishav Mehta
Ind-Swift Laboratories Ltd - Financial Statement
The financial statement of Ind-Swift Laboratories Limited has been mentioned in the table below:
Ind-Swift Laboratories Ltd - Products and Services
The different products and services produced by Ind-Swift Laboratories Ltd are mentioned below:
Macrolide Antibiotics
Cardiovascular
Anti Histamine
Anti Diabetic
Analgesic
Aromatase Inhibtors
Anti Depressant
Anti Diarrheoal
Alcohol Absistence
Anti Parkinson
Anti Psychotic
Ind-Swift Laboratories Ltd - Contact Details
Corporate Office:
S.C.O. 850,
Shivalik Enclave,
Manimajra
Chandigarh - 160101,
India
Phone: 91 172 2730503, 2730920, 5061850-53,
E mail: [email protected]
Last updated on 6thJuly 2011
A division of the Ind-swift Group, Ind-Swift Laboratories was founded in the year 1995. This leading pharmaceutical company went public in the year 1997. Ind-Swift Limited in collaboration with Punjab State Industrial Development Corporation Limited (PSIDC) promoted the growth of this firm. Within few years of its establishment, Ind-Swift Laboratories Ltd has earned world wide recognition as well as a Bulk-Actives supplier in over 40 countries.
The company mainly bases its production in the creation of Active Pharmaceutical Ingredients or API. Besides, its involvement in organic synthetic chemistry has helped Ind-Swift Laboratories Ltd. to emerge as leader in the production of various products not only in the Indian subcontinent as well as throughout the world. The products manufactured by this company include capsule, oral solution, eye and ear drops, tablets, creams and gels. The products manufactured by Ind-Swift Laboratories Ltd are mainly used in the antiallergy, macrolide antibiotic, diabetology, antiulcerant, cardiovascular therapeutic sector.
The manufacturing plants of the company engage in the production of USFDA approved products. In addition, the company follows a long term policy in various regulated markets such as drugs which is worth US $80 billion, in order to maintain its quality production. The shares of Ind-Swift Laboratories Ltd. are listed on Bombay, Delhi, National and Ludhiana stock exchanges.
Ind-Swift Laboratories Ltd is also engaged in research and development, commonly known as R&D. The company involves in the research for advanced intermediates, non-infringing processes development for promising molecules, contract research, process optimization as well as improvement, contract manufacturing and many more.
Ind-Swift Laboratories Ltd - Management
The management details of Ind-Swift Laboratories Ltd are mentioned below:
Ind-Swift Laboratories Ltd - Financial Statement
The financial statement of Ind-Swift Laboratories Limited has been mentioned in the table below:
| Particulars | March 31 2006 | March 31 2007 | March 31 2008 | March 31 2009 |
| Total Revenues | 3,145.4 | 3,531.0 | 4,577.8 | 5,902.0 |
| Gross Profit | 901.7 | 980.6 | 1,248.6 | 1,645.1 |
| Operating Income | 558.6 | 599.2 | 850.3 | 1,048.7 |
| Net Income | 334.9 | 182.4 | 314.2 | 403.9 |
Ind-Swift Laboratories Ltd - Products and Services
The different products and services produced by Ind-Swift Laboratories Ltd are mentioned below:
Corporate Office:
S.C.O. 850,
Shivalik Enclave,
Manimajra
Chandigarh - 160101,
India
Phone: 91 172 2730503, 2730920, 5061850-53,
5076458, 5086248,2738827,2738828,5072079,
5072079, 3292003
Fax: 91 172 2730504E mail: [email protected]
Last updated on 6thJuly 2011
